Neuron23® Inc., a clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, today announced that data from the ...
An international research team has conceived a dual-component controller for three-phase inverters that can reportedly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback